Medication-info.com Search Menu

Osvyrti (Denosumab): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning
Strength:
60 mg/mL
Other brand names:
Drug class:
Active ingredient:
Similar drugs:

Patient information: uses, side effects, how to take - Osvyrti

What is the most important information I should know about OSVYRTI?

If you receive OSVYRTI, you should not receive other denosumab products at the same time.

OSVYRTI can cause serious side effects including:

  • Increased risk of severe low calcium levels in your blood (hypocalcemia). OSVYRTI may lower the calcium levels in your blood. If you have low blood calcium before you start receiving OSVYRTI, it may get worse during treatment. Your low blood calcium must be treated before you receive OSVYRTI. Talk to your doctor before starting OSVYRTI. Your doctor may prescribe calcium and vitamin D to help prevent low calcium levels in your blood while you take OSVYRTI. Take calcium and vitamin D as your doctor tells you to.

    If you have advanced chronic kidney disease (may or may not be on kidney dialysis), OSVYRTI may increase your risk for severe low calcium levels in your blood, which could result in hospitalization, life-threatening events and death. A mineral and bone disorder associated with kidney disease called chronic kidney disease-mineral bone disorder (CKD-MBD) may increase your risk for severe low calcium levels in blood. Before you start OSVYRTI and during treatment, your doctor may need to do certain blood tests to check for CKD-MBD.

    Most people with low blood calcium levels do not have symptoms, but some people may have symptoms. Call your doctor right away if you have symptoms of low blood calcium such as:

    • spasms, twitches, or cramps in your muscles
    • numbness or tingling in your fingers, toes, or around your mouth
  • Serious allergic reactions. Serious allergic reactions have happened in people who take denosumab products. Call your doctor or go to your nearest emergency room right away if you have any symptoms of a serious allergic reaction. Symptoms of a serious allergic reaction may include:
  • low blood pressure (hypotension)
  • trouble breathing
  • throat tightness
  • swelling of your face, lips, or tongue
  • rash
  • itching
  • hives
  • Severe jaw bone problems (osteonecrosis). Severe jaw bone problems may happen when you take OSVYRTI. Your doctor should examine your mouth before you start OSVYRTI. Your doctor may tell you to see your dentist before you start OSVYRTI. It is important for you to practice good mouth care during treatment with OSVYRTI. Ask your doctor or dentist about good mouth care if you have any questions.
  • Unusual thigh bone fractures. Some people have developed unusual fractures in their thigh bone. Symptoms of a fracture include new or unusual pain in your hip, groin, or thigh.
  • Increased risk of broken bones, including broken bones in the spine, after stopping, skipping or delaying OSVYRTI.Talk with your doctor before starting OSVYRTI treatment. After your treatment with OSVYRTI is stopped, or if you skip or delay taking a dose, your risk for breaking bones, including bones in your spine, is increased. Your risk for having more than 1 broken bone in your spine is increased if you have already had a broken bone in your spine. Do not stop, skip or delay taking OSVYRTI without first talking with your doctor. If your OSVYRTI treatment is stopped, talk to your doctor about other medicine that you can take.
  • Serious infections. Serious infections in your skin, lower stomach area (abdomen), bladder, or ear may happen if you take OSVYRTI. Inflammation of the inner lining of the heart (endocarditis) due to an infection also may happen more often in people who take OSVYRTI. You may need to go to the hospital for treatment if you develop an infection.

    OSVYRTI is a medicine that may affect the ability of your body to fight infections. People who have a weakened immune system or take medicines that affect the immune system may have an increased risk for developing serious infections. Call your doctor right away if you have any of the following symptoms of infection:

    • fever or chills
    • skin that looks red or swollen and is hot or tender to touch
    • fever, shortness of breath, cough that will not go away
    • severe abdominal pain
    • frequent or urgent need to urinate or burning feeling when you urinate
  • Skin problems. Skin problems such as inflammation of your skin (dermatitis), rash, and eczema may happen if you take OSVYRTI. Call your doctor if you have any of the following symptoms of skin problems that do not go away or get worse:
  • redness
  • itching
  • small bumps or patches (rash)
  • your skin is dry or feels like leather
  • blisters that ooze or become crusty
  • skin peeling
  • Bone, joint, or muscle pain. Some people who take denosumab products develop severe bone, joint, or muscle pain.

Call your doctor right away if you have any of these side effects.

What is OSVYRTI?

OSVYRTI is a prescription medicine used to:

  • Treat osteoporosis (thinning and weakening of bone) in women after menopause ("change of life") who:

    • are at high risk for fracture (broken bone)
    • cannot use another osteoporosis medicine or other osteoporosis medicines did not work well
  • Increase bone mass in men with osteoporosis who are at high risk for fracture.
  • Treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least 6 months and are at high risk for fracture.
  • Treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body.
  • Treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.

    It is not known if OSVYRTI is safe and effective in children. OSVYRTI is not approved for use in children.

Do not take OSVYRTI if you:

  • have been told by your doctor that your blood calcium level is too low.
  • are pregnant or plan to become pregnant.

  • are allergic to denosumab or any of the ingredients in OSVYRTI. See the end of this Medication Guide for a complete list of ingredients in OSVYRTI.

Before taking OSVYRTI, tell your doctor about all of your medical conditions, including if you:

  • are taking other medicine containing denosumab.
  • have low blood calcium.
  • cannot take daily calcium and vitamin D.
  • had parathyroid or thyroid surgery (glands located in your neck).
  • have been told you have trouble absorbing minerals in your stomach or intestines (malabsorption syndrome).
  • have kidney problems or are on kidney dialysis.
  • are taking medicine that can lower your blood calcium levels.
  • plan to have dental surgery or teeth removed.
  • are pregnant or plan to become pregnant. OSVYRTI may harm your unborn baby.

    Females who are able to become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with OSVYRTI.
    • You should use an effective method of birth control (contraception) during treatment with OSVYRTI and for at least 5 months after your last dose of OSVYRTI.
    • Tell your doctor right away if you become pregnant while taking OSVYRTI.
  • are breastfeeding or plan to breastfeed. It is not known if OSVYRTI passes into your breast milk. You and your doctor should decide if you will take OSVYRTI or breastfeed. You should not do both.

Tell your doctor about all the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Know the medicines you take. Keep a list of medicines with you to show to your doctor or pharmacist when you get a new medicine.

How will I receive OSVYRTI?

  • OSVYRTI is an injection that will be given to you by a healthcare provider. OSVYRTI is injected under your skin (subcutaneous).
  • You will receive OSVYRTI 1 time every 6 months.
  • You should take calcium and vitamin D as your doctor tells you to while you receive OSVYRTI.
  • If you miss a dose of OSVYRTI, you should receive your injection as soon as you can.
  • Take good care of your teeth and gums while you receive OSVYRTI. Brush and floss your teeth regularly.
  • Tell your dentist that you are receiving OSVYRTI before you have dental work.

What are the possible side effects of OSVYRTI?

OSVYRTI may cause serious side effects.

  • See "What is the most important information I should know about OSVYRTI?"
  • It is not known if the use of OSVYRTI over a long period of time may cause slow healing of broken bones.

The most common side effects of OSVYRTI in women who are being treated for osteoporosis after menopause are:

  • back pain
  • pain in your arms and legs
  • high cholesterol
  • muscle pain
  • bladder infection

The most common side effects of OSVYRTI in men with osteoporosis are:

  • back pain
  • joint pain
  • common cold (runny nose or sore throat)

The most common side effects of OSVYRTI in patients with glucocorticoid-induced osteoporosis are:

  • back pain
  • high blood pressure
  • lung infection (bronchitis)
  • headache

The most common side effects of OSVYRTI in patients receiving certain treatments for prostate or breast cancer are:

  • joint pain
  • back pain
  • pain in your arms and legs
  • muscle pain

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of OSVYRTI.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088

How should I store OSVYRTI if I need to pick it up from a pharmacy?

  • Keep OSVYRTI refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton.
  • Do not freeze OSVYRTI.
  • When you remove OSVYRTI from the refrigerator, OSVYRTI must be kept at room temperature up to 77°F (25°C) in the original carton and must be used within 14 days.
  • Do not keep OSVYRTI at temperatures above 77°F (25°C). Warm temperatures will affect how OSVYRTI works.
  • Do not shake OSVYRTI.
  • Keep OSVYRTI in the original carton to protect from light.

Keep OSVYRTI and all medicines out of the reach of children.

General information about the safe and effective use of OSVYRTI.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use OSVYRTI for a condition for which it was not prescribed. Do not give OSVYRTI to other people, even if they have the same symptoms that you have. It may harm them. You can ask your doctor or pharmacist for information about OSVYRTI that is written for healthcare provider.

What are the ingredients in OSVYRTI?

Active ingredient: denosumab-desu

Inactive ingredients: glacial acetic acid, polysorbate 20, sodium hydroxide, sorbitol, and Water for Injection

Manufactured by: Accord BioPharma Inc., 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617 USA, U.S. License No. 2105

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: BLA 761424 · View the label on DailyMed

Revision date stated in the text: October 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Osvyrti

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class RANK Ligand Inhibitor
Active ingredient Denosumab 60 mg/mL
Dosage form Injection
Route Subcutaneous
Marketing status listed in the FDA NDC Directory
Company (applicant) ACCORD BIOPHARMA INC.
FDA approval BLA 761424Biologics License Application (BLA) Approved October 29, 2025
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
60 mg/mL – 1 ml in 1 syringe / 1 in 1 carton NDC 69448-021-63

Source: FDA drug labeling via NLM DailyMed, data as of November 5, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.